Targeting CGRP: A New Era for Migraine Treatment

CNS Drugs - United Kingdom
doi 10.1007/s40263-015-0253-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

New Trends in Migraine Pharmacology: Targeting Calcitonin Gene–Related Peptide (CGRP) With Monoclonal Antibodies

Frontiers in Pharmacology
Pharmacology
2019English

CGRP as a Migraine Inducing Substance

The Scientific World Journal
BiochemistryMedicineGeneticsMolecular BiologyEnvironmental Science
2001English

Calcitonin Gene-Related Peptide (CGRP) and Migraine

Headache
Neurology
2006English

A New Source of Information for a New Era in Treatment

Advances in Pulmonary Hypertension
2002English

A New Era for Immunotherapeutic Approaches in Multiple Sclerosis Treatment

Journal of Clinical Trials
2016English

Calcitonin Gene Related Peptide (CGRP) in Pain and Migraine: A Mini-Review

Endocrinology&Metabolism International Journal
2018English

Feasibility of Serum CGRP Measurement as a Biomarker of Chronic Migraine: A Critical Reappraisal

Journal of Headache and Pain
MedicineNeurologyAnesthesiologyPain Medicine
2018English

Treatment Options for Vestibular Migraine

US Neurology
NeuroscienceNeurology
2016English

Ineffective Acute Treatment of Episodic Migraine Is Associated With New-Onset Chronic Migraine

Neurology
Neurology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy